Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

ISNO consensus guidelines for practical adaptation of the WHO 2016 classification of adult diffuse gliomas.

Santosh V, Sravya P, Gupta T, Muzumdar D, Chacko G, Suri V, Epari S, Balasubramaniam A, Radotra BD, Chatterjee S, Sarkar C, Jalali R.

Neurol India. 2019 Jan-Feb;67(1):173-182. doi: 10.4103/0028-3886.253572.

2.

Indian Society of Neuro-Oncology consensus guidelines for the contemporary management of medulloblastoma.

Gupta T, Sarkar C, Rajshekhar V, Chatterjee S, Shirsat N, Muzumdar D, Pungavkar S, Chinnaswamy G, Jalali R.

Neurol India. 2017 Mar-Apr;65(2):315-332. doi: 10.4103/0028-3886.201841.

3.

A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource-limited set-up.

Rajeswarie RT, Rao S, Nandeesh BN, Yasha TC, Santosh V.

J Clin Pathol. 2018 Apr;71(4):323-329. doi: 10.1136/jclinpath-2017-204638. Epub 2017 Aug 11.

PMID:
28801347
4.

Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.

Wood MD, Halfpenny AM, Moore SR.

Diagn Pathol. 2019 Apr 9;14(1):29. doi: 10.1186/s13000-019-0802-8. Review.

5.

CGCG clinical practice guidelines for the management of adult diffuse gliomas.

Jiang T, Mao Y, Ma W, Mao Q, You Y, Yang X, Jiang C, Kang C, Li X, Chen L, Qiu X, Wang W, Li W, Yao Y, Li S, Li S, Wu A, Sai K, Bai H, Li G, Chen B, Yao K, Wei X, Liu X, Zhang Z, Dai Y, Lv S, Wang L, Lin Z, Dong J, Xu G, Ma X, Cai J, Zhang W, Wang H, Chen L, Zhang C, Yang P, Yan W, Liu Z, Hu H, Chen J, Liu Y, Yang Y, Wang Z, Wang Z, Wang Y, You G, Han L, Bao Z, Liu Y, Wang Y, Fan X, Liu S, Liu X, Wang Y, Wang Q; Chinese Glioma Cooperative Group (CGCG).

Cancer Lett. 2016 Jun 1;375(2):263-273. doi: 10.1016/j.canlet.2016.01.024. Epub 2016 Mar 7.

6.

Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.

Cimino PJ, Zager M, McFerrin L, Wirsching HG, Bolouri H, Hentschel B, von Deimling A, Jones D, Reifenberger G, Weller M, Holland EC.

Acta Neuropathol Commun. 2017 May 22;5(1):39. doi: 10.1186/s40478-017-0443-7.

7.

Diffuse Gliomas for Nonneuropathologists: The New Integrated Molecular Diagnostics.

Lee SC.

Arch Pathol Lab Med. 2018 Jul;142(7):804-814. doi: 10.5858/arpa.2017-0449-RA. Epub 2018 May 18.

PMID:
29775073
8.

International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading.

Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov A, Kros JM, Beatriz Lopes M, Ng HK, Ohgaki H, Paulus W, Pietsch T, Rosenblum M, Rushing E, Soylemezoglu F, Wiestler O, Wesseling P; International Society Of Neuropathology--Haarlem.

Brain Pathol. 2014 Sep;24(5):429-35. doi: 10.1111/bpa.12171. Epub 2014 Sep 10.

PMID:
24990071
9.

Towards an integrated morphological and molecular WHO diagnosis of central nervous system tumors: a paradigm shift.

Rushing EJ, Wesseling P.

Curr Opin Neurol. 2015 Dec;28(6):628-32. doi: 10.1097/WCO.0000000000000258. Review.

PMID:
26402407
10.

Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations.

DeWitt JC, Jordan JT, Frosch MP, Samore WR, Iafrate AJ, Louis DN, Lennerz JK.

Neuro Oncol. 2017 Nov 29;19(12):1640-1650. doi: 10.1093/neuonc/nox120.

11.

Advances in the molecular genetics of gliomas - implications for classification and therapy.

Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M.

Nat Rev Clin Oncol. 2017 Jul;14(7):434-452. doi: 10.1038/nrclinonc.2016.204. Epub 2016 Dec 29. Review.

12.

[Guidelines for adult diffuse gliomas WHO grade II, III and IV: pathology and biology. Société franc¸aise de neuropathologie . Réseau de neuro-oncologie pathologique].

Figarella-Branger D, Labrousse F, Mohktari K; Société franc¸aise de neuropathologie; Réseau de neuro-oncologie pathologique.

Ann Pathol. 2012 Oct;32(5):318-27. doi: 10.1016/j.annpat.2012.09.228. Epub 2012 Oct 23. French.

PMID:
23141938
13.

Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.

Aldape K, Nejad R, Louis DN, Zadeh G.

Neuro Oncol. 2017 Mar 1;19(3):336-344. doi: 10.1093/neuonc/now181.

14.

Current therapeutic approaches to diffuse grade II and III gliomas.

Picca A, Berzero G, Sanson M.

Ther Adv Neurol Disord. 2018 Jan 17;11:1756285617752039. doi: 10.1177/1756285617752039. eCollection 2018.

15.

WHO 2016 Classification of gliomas.

Wesseling P, Capper D.

Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150. doi: 10.1111/nan.12432. Review.

PMID:
28815663
16.

EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.

van de Velde CJ, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, Beets-Tan RG, van den Broek CB, Brown G, Van Cutsem E, Espin E, Haustermans K, Glimelius B, Iversen LH, van Krieken JH, Marijnen CA, Henning G, Gore-Booth J, Meldolesi E, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten H, Schmoll HJ, Smith JJ, Tanis PJ, Taylor C, Wibe A, Wiggers T, Gambacorta MA, Aristei C, Valentini V.

Eur J Cancer. 2014 Jan;50(1):1.e1-1.e34. doi: 10.1016/j.ejca.2013.06.048. Epub 2013 Oct 31.

PMID:
24183379
17.

2016 World Health Organization Classification of Central Nervous System Tumors.

Wen PY, Huse JT.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1531-1547. doi: 10.1212/CON.0000000000000536. Review.

PMID:
29200109
18.

Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016.

Sasaki H, Yoshida K.

Neurol Med Chir (Tokyo). 2017 Dec 15;57(12):658-666. doi: 10.2176/nmc.ra.2017-0071. Epub 2017 Aug 25. Review.

19.

[Standards, Options and Recommendations 2002 for the management of adult patients with intracranial gliomas (summary report)].

Frappaz D, Chinot O, Bataillard A, Ben Hassel M, Capelle L, Chanalet S, Chatel M, Figarella-Branger D, Guegan Y, Guyotat J, Khé HX, Jouanneau E, Keime-Guibert F, Laforêt C, Linassier C, Loiseau H, Menel P, Rousmans S, Sanson M, Sunyach MP.

Bull Cancer. 2003 Oct;90(10):873-86. Review. French. Erratum in: Bull Cancer. 2003 Dec;90(12):1096.

20.

Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results.

Ballester LY, Huse JT, Tang G, Fuller GN.

Hum Pathol. 2017 Nov;69:15-22. doi: 10.1016/j.humpath.2017.05.005. Epub 2017 May 23.

PMID:
28549927

Supplemental Content

Support Center